Gritstone bio (NASDAQ:GRTS) Downgraded by Zacks Investment Research to Hold

Gritstone bio stock has undergone multiple analysts rating changes in the recent past.  Gritstone bio Downgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

Shares of Gritstone bio traded up $0.13 on Tuesday, reaching $9.20. 0 shares of the stock traded hands, compared to its average volume of 1163288. Shares of Gritstone bio were trading at $9.20 on Tuesday. The firm’s 50 day moving average is $9.72 and its 200 day moving average is $10.49.Gritstone bio has a 12 month low of $8.73 and a 12 month high of $35.20. While on yearly highs and lows, Gritstone bio’s today has traded high as $9.28 and has touched $8.73 on the downward trend. See More Analyst Rating at: RATING

Gritstone bio Earnings and What to expect: 

Gritstone bio last issued its quarterly earnings data on August 5th, 2021. The reported ($0.33) EPS for the quarter, topping analysts’ consensus estimates of ($0.58) by $0.25. The company earned $2.84 million during the quarter, compared to the consensus estimate of $3 million. Gritstone bio has generated ($2.79) earnings per share over the last year (($1.61) diluted earnings per share). Earnings for Gritstone bio are expected to decrease in the coming year, from ($1.01) to ($1.22) per share. Gritstone bio has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 4th, 2021 based off prior year’s report dates.

Earnings for Gritstone bio are expected to decrease in the coming year, from ($1.01) to ($1.22) per share. The P/E ratio of Gritstone bio is -5.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Gritstone bio is -5.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Gritstone bio has a P/B Ratio of 2.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Gritstone bio (NASDAQ:GRTS) Moving Average Technical Analysis

5 day Moving Average is $9.31 And 5 day price change is -$0.60 (-6.12%)  with average volume for 5 day average is 589,280. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $10.85 and 20 day price change is -$2.38 (-20.55%) and average 20 day moving volume is 1,264,710. 50 day moving average is $9.72  and 50 day price change is $2.29 ( 33.14%)  and with average volume for 50 days is : 1,063,556. 200 day moving average is $10.49  and 200 day price change is $4.98 (118.01%)  and with average volume for 200 days is : 1,560,321.

Other owners latest trading in Gritstone bio :

  • On 9/17/2021 shares held by Virtu Financial LLC were 30,386 which equates to market value of $0.28M and appx 0.00% owners of Gritstone bio
  • On 8/25/2021 shares held by Marshall Wace LLP were 89,284 which equates to market value of $0.82M and appx 0.00% owners of Gritstone bio
  • On 8/23/2021 shares held by Morgan Stanley were 60,925 which equates to market value of $0.56M and appx 0.00% owners of Gritstone bio
  • In total Institutional ownership equates to Institutional Ownership Percentage: 70.55% for Gritstone bio

See More Analyst Rating at: RATING